2014
DOI: 10.3332/ecancer.2014.474
|View full text |Cite
|
Sign up to set email alerts
|

Primary cardiac lymphoma with isolated parenchymal central nervous system relapse: report of two cases and review of the literature

Abstract: Primary cardiac lymphoma (PCL) is a rare subset of non-Hodgkin’s lymphoma involving the heart and/or pericardium with no or minimal evidence of extracardiac involvement at presentation. Distant relapses have infrequently been observed.We report two cases of this disorder that showed isolated central nervous system (CNS) relapse. Diagnosis by endomyocardial biopsy was consistent with diffuse large B-cell lymphoma. After immunochemotherapy they achieved complete remission (CR). Eight and five weeks after, isolat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 11 publications
0
4
0
Order By: Relevance
“…Rarely, isolated extranodal and extracardiac relapse, for example, in the central nervous system, have been reported [21, 22]. Our patient relapsed after 7 years with an isolated breast lesion.…”
Section: Discussionmentioning
confidence: 57%
See 1 more Smart Citation
“…Rarely, isolated extranodal and extracardiac relapse, for example, in the central nervous system, have been reported [21, 22]. Our patient relapsed after 7 years with an isolated breast lesion.…”
Section: Discussionmentioning
confidence: 57%
“…A few cases of early relapse have been described in the literature [5, 21]. Rarely, isolated extranodal and extracardiac relapse, for example, in the central nervous system, have been reported [21, 22].…”
Section: Discussionmentioning
confidence: 99%
“…A few case reports (17-21) described isolated parenchymal CNS relapse in patients with PCL: in most cases, similarly to what happened in our patient, relapsed occurred shortly after the completion of chemotherapy (within two months) in responders. Only one patient had received CNS prophylaxis with intermediate-dose (1.5 g/m 2 ) methotrexate, administered every two weeks for four doses (20). A proportion of these patients responded to second-line therapy, but long-term followup is missing.…”
Section: Discussionmentioning
confidence: 99%
“…Our two patients developed a CNS relapse at 6 months and 2 years from initial diagnosis. We identified six additional PCL cases in the literature, who also developed isolated CNS recurrence of the lymphoma . CNS disease typically developed within a few months after initial presentation, raising the question whether occult CNS localization was already present at the time of diagnosis.…”
Section: Discussionmentioning
confidence: 99%